GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Probiotix Health PLC (AQSE:PBX) » Definitions » Common Stock

Probiotix Health (AQSE:PBX) Common Stock : £0.06 Mil (As of Jun. 2023)


View and export this data going back to 2022. Start your Free Trial

What is Probiotix Health Common Stock?

Probiotix Health's quarterly common stock declined from Jun. 2022 (£0.06 Mil) to Dec. 2022 (£0.05 Mil) but then increased from Dec. 2022 (£0.05 Mil) to Jun. 2023 (£0.06 Mil).

Probiotix Health's annual common stock stayed the same from Dec. 2019 (£0.00 Mil) to Dec. 2020 (£0.00 Mil) but then increased from Dec. 2020 (£0.00 Mil) to Dec. 2022 (£0.05 Mil).


Probiotix Health Common Stock Historical Data

The historical data trend for Probiotix Health's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Probiotix Health Common Stock Chart

Probiotix Health Annual Data
Trend Dec18 Dec19 Dec20 Dec22
Common Stock
- - - 0.05

Probiotix Health Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Jun22 Dec22 Jun23
Common Stock Get a 7-Day Free Trial - - 0.06 0.05 0.06

Probiotix Health Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.


Probiotix Health (AQSE:PBX) Business Description

Traded in Other Exchanges
Address
Nostell Business Estate, First Floor Zucchi Suite, Wakefield, GBR, WF4 1AB
Probiotix Health PLC develops probiotics to tackle cardiovascular disease and other lifestyle conditions which are affecting growing numbers of people across the world. The Company has one class of business, in three geographical areas being that of identifying and developing microbial strains, compounds and formulations for use in the nutraceutical industry.

Probiotix Health (AQSE:PBX) Headlines

No Headlines